Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Invesco India Pharma and Healthcare Fund · Regular ✕Aditya Birla Sun Life Business Cycle Fund · Regular ✕

Growth of ₹10,000

Basics

Invesco India Pharma and Healthcare FundAditya Birla Sun Life Business Cycle Fund
CategorySectoral / ThematicSectoral / Thematic
PlanRegularRegular
Fund houseInvescoABSL
NAV₹10.7400₹16.3400
NAV date20 Nov 202619 Nov 2026
History2 months4.9 years
Expense ratio3.8%2.5%
StarsNot rated★★★★★
Growth Score—57.60

Returns

Invesco India Pharma and Healthcare FundAditya Birla Sun Life Business Cycle Fund
1 month+19.60%+5.42%
3 months—−0.31%
6 months—+10.85%
YTD—+5.08%
1 year—+4.48%
3 years (CAGR)—+12.39%
5 years (CAGR)——
10 years (CAGR)——
Since launch+7.29%+10.25%

Risk

Invesco India Pharma and Healthcare FundAditya Birla Sun Life Business Cycle Fund
Volatility—15.3%
Downside volatility—10.5%
Sharpe—0.38
Sortino—0.56
Calmar—0.68
Return / risk—0.81
Deepest fall−11.50%−18.14%
Days to recover14513
Below its high+0.00%−1.98%

Against benchmark

Invesco India Pharma and Healthcare FundAditya Birla Sun Life Business Cycle Fund
Alpha—+0.88%
Beta—0.92
R²—92.8%
Up capture—99.9%
Down capture—96.5%
Tracking error—4.3%
Information ratio—0.10
Treynor—0.06

Consistency

Invesco India Pharma and Healthcare FundAditya Birla Sun Life Business Cycle Fund
Best 1-year—+39.74%
Middle 1-year—+8.95%
Worst 1-year—−7.76%
1-year periods with a loss—11.0%
Middle 3-year—+13.25%
Positive months—66.7%
Best day+3.52%+3.91%
Worst day−2.74%−5.70%
Worst 5% day−1.46%−1.35%
Positive days46.8%54.3%
NAVs a year48247

SIP of ₹10,000 a month

Invesco India Pharma and Healthcare FundAditya Birla Sun Life Business Cycle Fund
5-year XIRR——
5-year value——
3-year XIRR—+8.09%
1-year XIRR—+11.15%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth